Cardiovascular diseases (CVDs) are a set of heart and blood vessel disorders that include
coronary heart disease (CHD), rheumatic heart disease, and other conditions. Traditional …

The hallmark of heart failure (HF) is structural myocardial remodeling including
cardiomyocyte hypertrophy, fibrosis, cardiomyocyte cell death, and a low-grade aseptic …

Cardiomyopathies are a clinically heterogeneous group of cardiac diseases characterized
by heart muscle damage, resulting in myocardium disorders, diminished cardiac function …

Acute heart failure (AHF) is a life-threatening condition with high morbidity and mortality.
Even though this pathology has been extensively researched, there are still challenges in …

Myocardial ischemia reduces the supply of oxygen and nutrients to cardiomyocytes, leading
to an energetic crisis or cell death. Mitochondrial dysfunction is a decisive contributor to the …

Ischemic cardiomyopathy (ICM) is the most prevalent cause of heart failure (HF) in
developed countries, with significant morbidity and mortality, despite constant improvements …

Although major pathogenesis mechanisms of heart failure (HF) are well established, the
significance of early (mal) adaptive structural changes of cardiomyocytes preceding …

Background and aim Heart failure (HF) is an important complication of ST-elevation
myocardial infarction (STEMI), including early-and late-onset HF. This study aimed to …

Fibrotic scarring and impaired myocardial calcium homeostasis serve as the two main
factors in the pathology of heart failure following myocardial infarction (MI), leading to poor …

Cardiac myosin-specific (MyHC) T cells drive the disease pathogenesis of immune
checkpoint inhibitor–associated myocarditis (ICI-myocarditis). To determine whether MyHC …